Vesteck key facts
as of Oct 2026- Developer of medical devices designed to treat patients diagnosed with aortic disease.
- Vesteck is valued at approximately $1.9M as of Oct 2026, set at its later-stage round, Oct 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $26.1M across 2 recorded rounds; the latest was Seed Round ($2.3M) in Dec 2022.
- Notable investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, Robin Hood Ventures, BioAdvance Capital (Conshohocken), The Entrust Group, Angel Star Ventures — 11 tracked in total.
- Vesteck has filed 2 Form Ds with the SEC since 2021, most recently Jan 2023 ($2.3M sold to 30 investors).
- Status: Privately Held (backing).
Valued at $1.9M at its later-stage round, Oct 2025. Nothing has traded since.
- ·The complete investor list: 11 names
- ·Watch Vesteck: the Monday email on marks, rounds and moves
Vesteck funding rounds
2 roundsWho backs Vesteck
11+Vesteck valuation
Vesteck was valued at $1.9 million at its later-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Vesteck raised?
Vesteck has raised $26.1 million in total; 2 of its rounds are on record. The largest on record was a $4.4 million seed round in Aug 2021; the most recent was a $2.3 million seed round in Dec 2022.
Vesteck has filed 2 Form Ds with the SEC since 2021, most recently in Jan 2023 ($2.3 million sold to 30 investors).
Vesteck investors
11 investors are on record for Vesteck, including Ben Franklin Technology Partners of Southeastern Pennsylvania, Robin Hood Ventures, BioAdvance Capital (Conshohocken) and The Entrust Group. The seed round in Dec 2022 drew 30 investors.
About Vesteck
Developer of medical devices designed to treat patients diagnosed with aortic disease. The company offers devices that suture endovascular grafts to the aorta during implant or repair procedures, virtually eliminating graft migration and leaks, enabling endovascular providers, payors, and patients to gain greater procedural stability and long-term therapeutic benefit.
- Sector
- Healthcare
- HQ
- West Chester, PA, United States
- Founded
- 2019
- Employees
- 5
- Website
- vesteck.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.